As Dr. Mercola reports, butyrate is much more than just a nutrient for the colon. It is a key metabolite of the gut microbiota that also acts as a signaling molecule and can influence systemic processes. Butyrate is not simply "food for the colon"; it is a communication molecule between the microbiota and virtually the entire body.
Potential benefits of butyrate beyond the gut:
• Brain and nervous system: It can influence gut-brain communication, neuroinflammation, and the function of the blood-brain barrier. Furthermore, it inhibits HDAC enzymes, thus potentially modifying the expression of certain genes related to neuronal plasticity.
• Immune system: It helps regulate the immune response, promoting a balance between inflammation and tolerance. It can increase the activity of regulatory T cells and contribute to a less excessive immune response.
• Systemic inflammation: Butyrate has anti-inflammatory properties and can decrease certain pro-inflammatory pathways, such as NF-κB. Therefore, its potential role in inflammatory and metabolic diseases is being investigated.
• Cardiovascular metabolism: research links short-chain fatty acids to improved regulation of blood pressure, energy metabolism, and vascular function. Butyrate may play a role in these effects, although clinical evidence in humans is still limited.
• Glucose metabolism: it can improve insulin sensitivity and modify hormonal signals related to satiety and energy metabolism. This is particularly interesting because butyrate directly connects microbiota activity with host metabolism.
• Mitochondria and cellular energy: it can be used as an energy source and also act as a metabolic signal, influencing mitochondrial function and the utilization of energy substrates.
• Epigenetic regulation: this is one of its most interesting characteristics. Butyrate is a natural inhibitor of histone deacetylases (HDACs). This means it can modify gene expression without changing the DNA sequence. This is one of the reasons why it is studied in relation to aging, inflammation, and cancer.
• Intestinal barrier and defense against disease: although we are partially returning to the gut here, its consequences can be systemic: a more intact intestinal barrier can reduce the passage of pro-inflammatory molecules into the bloodstream.
Research, information pointing once again to the Mind Gut connection. Body Gut, Immune System, Gut, Heart, Gut, Insulin, Gut, our Mitochondria Power Plant Energy production and Gut Connections.
The importance of quality, nutritious foods supporting the Gut, supports all the health providing systems down the line. Quite the tell why such high levels of today's Chronic Dis - Ease Levels fed by a Toxic Chemical Loaded empty of Nutrition Calories marketing as "cheap food" tearing us down from the inside.
Ultra Processed fare high jacks the natural signals to tell us a food is safe, or good for us back in a time when foods were as natural as natural gets. The shelves are filled with Ultra Processed Gut and Health Offenders created to make us consume empty toxic calories.
Who would have ever thought we would need a break in period to heal, repair ourselves to consume actual healthy fare, if we can find it. Too, so many med's disrupt, interfere with the microbes, other things likely to support, work with the Butyrate.
Yes, just, great importance of gut health, great importance of butyrate. Increased dietary fiber intake has been associated with many beneficial effects, including improvements in obesity, insulin resistance, and cancer. Under normal conditions, carbohydrate fermentation maintains the stability of the gut microbiota; however, in chronic diseases, microbiota diversity decreases, and the metabolic pathway shifts from carbohydrate to protein fermentation, thus inhibiting butyrate production. Polysaccharides and proteins play a key role in regulating butyrate synthesis. As fermentable carbon sources, polysaccharides promote probiotic proliferation, reduce colonic pH, and inhibit anaerobic protein fermentation. However, excessive protein fermentation produces branched-chain fatty acids (BCFAs), ammonia, phenols, and other metabolites that inhibit butyrate production.
These effects may be due to the increased production of short-chain fatty acids, including propionate, acetate, and butyrate, during the fermentation of dietary fiber in the colon. In fact, oral and dietary butyrate supplementation alone has been shown to prevent obesity and insulin resistance induced by a high-fat diet. This review focuses on sources of short-chain fatty acids, with an emphasis on butyrate sources, the mechanisms of fiber and butyrate metabolism in the gut, their protective effects against colon cancer, and the peripheral effects of butyrate supplementation in peripheral tissues on the prevention and reversal of cancer, obesity, and insulin resistance. It should also be noted that bovine milk fat is a particularly rich source of butyrate, contributing approximately 4% by weight. Human breast milk has also been examined as a potential source of butyrate for newborns and as a modulator of the colonic microbiota. Recent pyrosequencing experiments have identified butyrogenic bacteria in human breast milk that may facilitate colonization of the neonatal colon.
Although numerous bacterial strains have been analyzed for their butyrate-producing capacity, Faecalibacterium prausnitzii and Eubacterium rectale/Roseburia have recently received the most attention, as they constitute 5% to 10% of the total bacteria in fecal samples collected from healthy adults. In addition to colon colonization by butyrogenic bacteria, it has been proposed that cross-feeding interactions between bifidobacterial strains and F. prausnitzii may ultimately enhance butyrate production. Butyrate is known to promote colonic epithelial growth but exerts a predominantly inhibitory effect on colorectal cancers.
Emerging evidence suggests that the paradoxical effects of butyrate can be explained by the Warburg effect observed in various types of cancer. Butyrate is not only responsible for the energy requirements of the colonic epithelium, but it also preserves these tissues by mitigating chronic inflammatory responses. Treatments with butyrate, or those that increase butyrate production, such as increased dietary fiber or bacterial colonization in the gut, have also been shown to prevent or attenuate obesity and insulin resistance. In addition to its preventive effects on body weight and adiposity, butyrate supplementation has also been associated with mitigating insulin resistance. Butyrate may regulate lipid metabolism in the liver and intestine, and several findings have demonstrated that it exerts beneficial effects on liver diseases. It is capable of downregulating the expression of nine key genes involved in the intestinal cholesterol biosynthesis pathway and, therefore, may inhibit hypercholesterolemia. Butyrate administration improves HFD-induced hepatic steatosis in mice by reducing intrahepatic lipid accumulation (triglyceride and phospholipid content) and liver weight. In-depth mechanistic research focused on the liver has shown that hepatic mitochondria are the primary target of butyrate's beneficial effect in reversing fat accumulation in diet-induced obesity. Islets are known to express the butyrate receptors GPR41 and 43, suggesting that butyrate may be involved in islet cell metabolism and function, as evidenced by the effects of butyrate pre-incubation on improving diabetes-induced islet histological alteration and functional damage. Butyrate is also capable of stimulating GLP-1 release from intestinal L cells. GLP-1 has the ability to reduce apoptosis and induce neogenesis and regeneration of pancreatic β cells, as well as induce insulin synthesis and secretion.
Isobutyrate is less readily absorbed and metabolized compared to butyrate, but it can act as an alternative energy source when butyrate levels are low or when butyrate oxidation is abnormal.
Butyrate also exerts dose-dependent effects on HCT-116 colorectal cancer cells, significantly reducing viability, cell proliferation, and confluence at certain concentrations. It induces apoptosis and cell cycle arrest by overexpressing pro-apoptotic genes and underexpressing anti-apoptotic and proliferative markers.
Acetate, propionate, and butyrate are the three main SCFAs, and their bioactivities have been extensively studied. SCFAs have many health benefits, such as anti-inflammatory, immunoregulatory, anti-obesity, anti-diabetic, anti-cancer, cardiovascular protective, hepatoprotective, and neuroprotective activities.
As Dr. Mercola reports, butyrate is much more than just a nutrient for the colon. It is a key metabolite of the gut microbiota that also acts as a signaling molecule and can influence systemic processes. Butyrate is not simply "food for the colon"; it is a communication molecule between the microbiota and virtually the entire body.
Potential benefits of butyrate beyond the gut:
• Brain and nervous system: It can influence gut-brain communication, neuroinflammation, and the function of the blood-brain barrier. Furthermore, it inhibits HDAC enzymes, thus potentially modifying the expression of certain genes related to neuronal plasticity.
• Immune system: It helps regulate the immune response, promoting a balance between inflammation and tolerance. It can increase the activity of regulatory T cells and contribute to a less excessive immune response.
• Systemic inflammation: Butyrate has anti-inflammatory properties and can decrease certain pro-inflammatory pathways, such as NF-κB. Therefore, its potential role in inflammatory and metabolic diseases is being investigated.
• Cardiovascular metabolism: research links short-chain fatty acids to improved regulation of blood pressure, energy metabolism, and vascular function. Butyrate may play a role in these effects, although clinical evidence in humans is still limited.
• Glucose metabolism: it can improve insulin sensitivity and modify hormonal signals related to satiety and energy metabolism. This is particularly interesting because butyrate directly connects microbiota activity with host metabolism.
• Mitochondria and cellular energy: it can be used as an energy source and also act as a metabolic signal, influencing mitochondrial function and the utilization of energy substrates.
• Epigenetic regulation: this is one of its most interesting characteristics. Butyrate is a natural inhibitor of histone deacetylases (HDACs). This means it can modify gene expression without changing the DNA sequence. This is one of the reasons why it is studied in relation to aging, inflammation, and cancer.
• Intestinal barrier and defense against disease: although we are partially returning to the gut here, its consequences can be systemic: a more intact intestinal barrier can reduce the passage of pro-inflammatory molecules into the bloodstream.
https://pubmed.ncbi.nlm.nih.gov/38565643/ (2024)
https://pubmed.ncbi.nlm.nih.gov/38641025/ (2024)
https://pubmed.ncbi.nlm.nih.gov/40284169/ (2025)
https://www.frontiersin.org/journals/cardiovascular-medicine/articles/10.3389/fcvm.2025.1608658/full (2025)
https://pubmed.ncbi.nlm.nih.gov/40557239/ (2025)
https://pubmed.ncbi.nlm.nih.gov/41683715/ (2026)
https://link.springer.com/article/10.1007/s11259-026-11307-z (2026)
https://www.mdpi.com/1422-0067/27/3/1289 (2026)
Research, information pointing once again to the Mind Gut connection. Body Gut, Immune System, Gut, Heart, Gut, Insulin, Gut, our Mitochondria Power Plant Energy production and Gut Connections.
The importance of quality, nutritious foods supporting the Gut, supports all the health providing systems down the line. Quite the tell why such high levels of today's Chronic Dis - Ease Levels fed by a Toxic Chemical Loaded empty of Nutrition Calories marketing as "cheap food" tearing us down from the inside.
Ultra Processed fare high jacks the natural signals to tell us a food is safe, or good for us back in a time when foods were as natural as natural gets. The shelves are filled with Ultra Processed Gut and Health Offenders created to make us consume empty toxic calories.
Who would have ever thought we would need a break in period to heal, repair ourselves to consume actual healthy fare, if we can find it. Too, so many med's disrupt, interfere with the microbes, other things likely to support, work with the Butyrate.
Yes, just, great importance of gut health, great importance of butyrate. Increased dietary fiber intake has been associated with many beneficial effects, including improvements in obesity, insulin resistance, and cancer. Under normal conditions, carbohydrate fermentation maintains the stability of the gut microbiota; however, in chronic diseases, microbiota diversity decreases, and the metabolic pathway shifts from carbohydrate to protein fermentation, thus inhibiting butyrate production. Polysaccharides and proteins play a key role in regulating butyrate synthesis. As fermentable carbon sources, polysaccharides promote probiotic proliferation, reduce colonic pH, and inhibit anaerobic protein fermentation. However, excessive protein fermentation produces branched-chain fatty acids (BCFAs), ammonia, phenols, and other metabolites that inhibit butyrate production.
These effects may be due to the increased production of short-chain fatty acids, including propionate, acetate, and butyrate, during the fermentation of dietary fiber in the colon. In fact, oral and dietary butyrate supplementation alone has been shown to prevent obesity and insulin resistance induced by a high-fat diet. This review focuses on sources of short-chain fatty acids, with an emphasis on butyrate sources, the mechanisms of fiber and butyrate metabolism in the gut, their protective effects against colon cancer, and the peripheral effects of butyrate supplementation in peripheral tissues on the prevention and reversal of cancer, obesity, and insulin resistance. It should also be noted that bovine milk fat is a particularly rich source of butyrate, contributing approximately 4% by weight. Human breast milk has also been examined as a potential source of butyrate for newborns and as a modulator of the colonic microbiota. Recent pyrosequencing experiments have identified butyrogenic bacteria in human breast milk that may facilitate colonization of the neonatal colon.
Although numerous bacterial strains have been analyzed for their butyrate-producing capacity, Faecalibacterium prausnitzii and Eubacterium rectale/Roseburia have recently received the most attention, as they constitute 5% to 10% of the total bacteria in fecal samples collected from healthy adults. In addition to colon colonization by butyrogenic bacteria, it has been proposed that cross-feeding interactions between bifidobacterial strains and F. prausnitzii may ultimately enhance butyrate production. Butyrate is known to promote colonic epithelial growth but exerts a predominantly inhibitory effect on colorectal cancers.
Emerging evidence suggests that the paradoxical effects of butyrate can be explained by the Warburg effect observed in various types of cancer. Butyrate is not only responsible for the energy requirements of the colonic epithelium, but it also preserves these tissues by mitigating chronic inflammatory responses. Treatments with butyrate, or those that increase butyrate production, such as increased dietary fiber or bacterial colonization in the gut, have also been shown to prevent or attenuate obesity and insulin resistance. In addition to its preventive effects on body weight and adiposity, butyrate supplementation has also been associated with mitigating insulin resistance. Butyrate may regulate lipid metabolism in the liver and intestine, and several findings have demonstrated that it exerts beneficial effects on liver diseases. It is capable of downregulating the expression of nine key genes involved in the intestinal cholesterol biosynthesis pathway and, therefore, may inhibit hypercholesterolemia. Butyrate administration improves HFD-induced hepatic steatosis in mice by reducing intrahepatic lipid accumulation (triglyceride and phospholipid content) and liver weight. In-depth mechanistic research focused on the liver has shown that hepatic mitochondria are the primary target of butyrate's beneficial effect in reversing fat accumulation in diet-induced obesity. Islets are known to express the butyrate receptors GPR41 and 43, suggesting that butyrate may be involved in islet cell metabolism and function, as evidenced by the effects of butyrate pre-incubation on improving diabetes-induced islet histological alteration and functional damage. Butyrate is also capable of stimulating GLP-1 release from intestinal L cells. GLP-1 has the ability to reduce apoptosis and induce neogenesis and regeneration of pancreatic β cells, as well as induce insulin synthesis and secretion.
Isobutyrate is less readily absorbed and metabolized compared to butyrate, but it can act as an alternative energy source when butyrate levels are low or when butyrate oxidation is abnormal.
Butyrate also exerts dose-dependent effects on HCT-116 colorectal cancer cells, significantly reducing viability, cell proliferation, and confluence at certain concentrations. It induces apoptosis and cell cycle arrest by overexpressing pro-apoptotic genes and underexpressing anti-apoptotic and proliferative markers.
Acetate, propionate, and butyrate are the three main SCFAs, and their bioactivities have been extensively studied. SCFAs have many health benefits, such as anti-inflammatory, immunoregulatory, anti-obesity, anti-diabetic, anti-cancer, cardiovascular protective, hepatoprotective, and neuroprotective activities.
https://www.mdpi.com/2072-6643/9/12/1348 (2017).---
https://www.mdpi.com/1420-3049/26/3/682/htm (2021).---
https://www.sciencedirect.com/science/article/abs/pii/S1043276020302526 (2021).--
https://lipidworld.biomedcentral.com/articles/10.1186/s12944-021-01491-z (2021).--
https://onlinelibrary.wiley.com/doi/full/10.1111/obr.13498 (2022).--
https://www.mdpi.com/2304-8158/11/18/2863 (2022).--
https://royalsocietypublishing.org/doi/full/10.1098/rsob.230014 (2023).--
https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2023.1110235/full (2023).--
https://onlinelibrary.wiley.com/doi/abs/10.1002/mnfr.202400421 (2024).--
https://www.spandidos-publications.com/ijo/64/4/44 (2024).---
https://pmc.ncbi.nlm.nih.gov/articles/PMC12162265/ (2025).—
https://pmc.ncbi.nlm.nih.gov/articles/PMC11766496/ (2025).—
https://www.mdpi.com/2304-8158/14/21/3649 (2025).--
I have been trying for weeks to order the Butyrate.